Literature DB >> 8602004

Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

A D Ogilvie1, S Battersby, V J Bubb, G Fink, A J Harmar, G M Goodwim, C A Smith.   

Abstract

UNLABELLED: BACKGROUND; The serotonin transporter of the brain provides the primary target for the action of selective antidepressant drugs. We set out to identify polymorphisms of the serotonin transporter gene and to find out whether there was a relation between any such polymorphisms and the occurrence of affective disorder.
METHODS: A comparison of a polymorphic region of the human serotonin transporter gene was carried out between two groups. The study group comprised 83 patients (39 unipolar depressive disorder, 44 bipolar disorder) with major affective disorder. The control group comprised 122 anonymous blood donors, and 71 volunteers who had been screened for psychiatric disorders.
FINDINGS: We detected three novel alleles of the variable-number-tandem-repeat (VNTR) region (STin2.9, STin2.10) and Stin2.12) containing nine, ten and 12 copies of the VNTR element, respectively. The frequencies of the different forms of the allele in the control group were compared with those in the affective disorder group. There was a significant difference between the control and affective disorder groups, largely explained by the excess of the STin2.9 allele in the unipolar group (chi2=10.05, p<0.004 [Bonferroni corrected]). The presence of the allele with nine copies of the repeat was significantly associated with risk of unipolar disorder (odds ratio=6.95 [95% CI 1.8-27.2]).
INTERPRETATION: This association, for an obvious candidate gene, may provide a critical starting point for an understanding of the likely polygenic contributions towards susceptibility to affective disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602004     DOI: 10.1016/s0140-6736(96)90079-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  84 in total

Review 1.  The heritability of postpartum depression.

Authors:  Elizabeth J Corwin; Ruth Kohen; Monica Jarrett; Brian Stafford
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

Review 2.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

3.  Genetic polymorphism of pri-microRNA 325, targeting SLC6A4 3'-UTR, is closely associated with the risk of functional dyspepsia in Japan.

Authors:  Tomiyasu Arisawa; Tomomitsu Tahara; Tomoki Fukuyama; Ranji Hayashi; Kazuhiro Matsunaga; Nobuhiko Hayashi; Masakatsu Nakamura; Nobuyuki Toshikuni; Hisakazu Shiroeda; Tomoyuki Shibata
Journal:  J Gastroenterol       Date:  2012-03-22       Impact factor: 7.527

Review 4.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

5.  Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.

Authors:  Alexandra Miller; Hoa Vo; Liang Huo; Catherine Roca; Peter J Schmidt; David R Rubinow
Journal:  J Psychiatr Res       Date:  2010-02-20       Impact factor: 4.791

6.  The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients.

Authors:  Yuyuan Li; Yuqiang Nie; Jun Xie; Weizhan Tang; Peizhi Liang; Weihong Sha; Hui Yang; Yonyjian Zhou
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

Review 7.  Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors:  Magnus Lekman; Silvia Paddock; Francis J McMahon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

8.  Reduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studies.

Authors:  Teresa M Karrer; Casey L McLaughlin; Carmela P Guaglianone; Gregory R Samanez-Larkin
Journal:  Neurobiol Aging       Date:  2019-04-05       Impact factor: 4.673

9.  Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine.

Authors:  A Pringle; K A Jennings; S Line; D M Bannerman; S Higgs; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  2008-06-16       Impact factor: 4.530

10.  Interspecies and intraspecies variations in the serotonin transporter gene intron 3 VNTR in nonhuman primates.

Authors:  Miho Inoue-Murayama; Emi Hibino; Hiromi Iwatsuki; Eiji Inoue; Kyung-Won Hong; Toshisada Nishida; Ikuo Hayasaka; Shin'ichi Ito; Yuichi Murayama
Journal:  Primates       Date:  2008-01-18       Impact factor: 2.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.